Finally, a recent study (Khoury et al., 2024) involving 752 patients with an AD diagnosis reported that female APOE4 homozygote carriers had worse neuropsychiatric symptoms and reduced cortical thickness, particularly in the medial-lateral temporal regions, compared to APOE4 homozygous males. The gene discussed is APOE; the disease is Alzheimer disease.